-
1
-
-
33947285787
-
Behçet's syndrome: Disease manifestations, management, and advances in treatment
-
DOI 10.1038/ncprheum0436, PII NCPRHEUM0436
-
Yazici H, Fresko I, Yurdakul S. Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007;3:148-55. (Pubitemid 46416263)
-
(2007)
Nature Clinical Practice Rheumatology
, vol.3
, Issue.3
, pp. 148-155
-
-
Yazici, H.1
Fresko, I.2
Yurdakul, S.3
-
2
-
-
0025360899
-
Criteria for diagnosis of Behçet's disease
-
International Study Group for Behçet's Disease
-
International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
-
(1990)
Lancet
, vol.335
, pp. 1078-1080
-
-
-
3
-
-
0000718206
-
Über residivierende, aphtöse durch ein virus verursachtes Geschwüre am Mund, am Auge und an der Genitalien
-
Behçet H. Über residivierende, aphtöse durch ein virus verursachtes Geschwüre am Mund, am Auge und an der Genitalien. Derm Wschr 1937;105:1152-7.
-
(1937)
Derm Wschr
, vol.105
, pp. 1152-1157
-
-
Behçet, H.1
-
4
-
-
58249144864
-
Neuro-Behçet's disease: Epidemiology, clinical characteristics, and management
-
Al-Araji A, Kidd D. Neuro-Behçet's disease: epidemiology, clinical characteristics, and management. Lancet Neurol 2009;8:192-204.
-
(2009)
Lancet Neurol
, vol.8
, pp. 192-204
-
-
Al-Araji, A.1
Kidd, D.2
-
5
-
-
0037246320
-
The long-term mortality and morbidity of Behçet syndrome: A 2-decade outcome survey of 387 patients followed at a dedicated center
-
DOI 10.1097/00005792-200301000-00006
-
Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated centre. Medicine (Baltimore) 2003;82:60-76. (Pubitemid 36139801)
-
(2003)
Medicine
, vol.82
, Issue.1
, pp. 60-76
-
-
Kural-Seyahi, E.1
Fresko, I.2
Seyahi, N.3
Ozyazgan, Y.4
Mat, C.5
Hamuryudan, V.6
Yurdakul, S.7
Yazici, H.8
-
7
-
-
34347363136
-
Clinical characteristics and course of spinal cord involvement in Behçet's disease
-
DOI 10.1111/j.1468-1331.2007.01754.x
-
Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman- Demir G. Clinical characteristics and course of spinal cord involvement in Behçet's disease. Eur J Neurol 2007;14:729-37. (Pubitemid 47012165)
-
(2007)
European Journal of Neurology
, vol.14
, Issue.7
, pp. 729-737
-
-
Yesilot, N.1
Mutlu, M.2
Gungor, O.3
Baykal, B.4
Serdaroglu, P.5
Akman-Demir, G.6
-
8
-
-
0032745188
-
Clinical patterns of neurological involvement in Behçet's disease: Evaluation of 200 patients
-
Neuro-Behçet Study Group
-
Akman-Demir G, Serdaroglu P, Tasçi B, Neuro-Behçet Study Group. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 1999;122:2171-81.
-
(1999)
Brain
, vol.122
, pp. 2171-2181
-
-
Akman-Demir, G.1
Serdaroglu, P.2
Tasçi, B.3
-
9
-
-
0029662248
-
Cytokines in Behçet's disease
-
Sayinalp N, Ozcebe OI, Ozdemir O, Haznedaroglu IC, Dündar S, Kirazli S. Cytokines in Behçet's disease. J Rheumatol 1996;23(2):321-2.
-
(1996)
J Rheumatol
, vol.23
, Issue.2
, pp. 321-322
-
-
Sayinalp, N.1
Ozcebe, O.I.2
Ozdemir, O.3
Haznedaroglu, I.C.4
Dündar, S.5
Kirazli, S.6
-
10
-
-
79955985681
-
Adalimumab (HumiraTM): A promising monoclonal anti-tumour necrosis factor alpha in ophthalmology
-
Neri P, Zucchi M, Allegri P, Lettieri M, Mariotti C, Giovannini A. Adalimumab (HumiraTM): a promising monoclonal anti-tumour necrosis factor alpha in ophthalmology. Int Ophthalmol 2011;31(2):164-73.
-
(2011)
Int Ophthalmol
, vol.31
, Issue.2
, pp. 164-173
-
-
Neri, P.1
Zucchi, M.2
Allegri, P.3
Lettieri, M.4
Mariotti, C.5
Giovannini, A.6
-
11
-
-
79958862562
-
Successful treatment with adalimumab in a familial case of gastrointestinal Behçet's disease
-
De Cassan C, De Vroey B, Dussault C, Hachulla E, Buche S, Colombel JF. Successful treatment with adalimumab in a familial case of gastrointestinal Behçet's disease. J Crohns Colitis 2011;5(4):364-8.
-
(2011)
J Crohns Colitis
, vol.5
, Issue.4
, pp. 364-368
-
-
De Cassan, C.1
De Vroey, B.2
Dussault, C.3
Hachulla, E.4
Buche, S.5
Colombel, J.F.6
-
12
-
-
39449127014
-
Infliximab for the treatment of neuro-Behçet's disease: A case series and review of the literature
-
DOI 10.1002/art.23345
-
Piptone N, Olivieri I, Padula A, D'angelo S, Nigro A, Zuccoli G, et al. Infliximab for the treatment of neuro-Behçet's disease: a case series and review of the literature. Arthritis Rheum 2008;59:285-90. (Pubitemid 351272967)
-
(2008)
Arthritis Care and Research
, vol.59
, Issue.2
, pp. 285-290
-
-
Pipitone, N.1
Olivieri, I.2
Padula, A.3
D'Angelo, S.4
Nigro, A.5
Zuccoli, G.6
Boiardi, L.7
Salvarani, C.8
-
13
-
-
79959599276
-
Anti-TNF agents for Behçet's disease: Analysis of published data on 369 patients
-
Arida A, Fragiadaki K, Giavri E, Sfikakis PP. Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum 2011;41(1):61-70.
-
(2011)
Semin Arthritis Rheum
, vol.41
, Issue.1
, pp. 61-70
-
-
Arida, A.1
Fragiadaki, K.2
Giavri, E.3
Sfikakis, P.P.4
-
14
-
-
79959591365
-
Infliximab for patients with neuro-Behçet's disease: Case series and literature review
-
Borhani Haghighi A, Safari A, Nazarinia MA, Habibagahi Z, Shenavandeh S. Infliximab for patients with neuro-Behçet's disease: case series and literature review. Clin Rheumatol 2011;30(7):1007-12.
-
(2011)
Clin Rheumatol
, vol.30
, Issue.7
, pp. 1007-1012
-
-
Borhani Haghighi, A.1
Safari, A.2
Nazarinia, M.A.3
Habibagahi, Z.4
Shenavandeh, S.5
-
15
-
-
79955838621
-
Treatment of neuro-Behçet's disease with infliximab: An international muticentre case-series of 18 patients
-
abstract
-
Al-Araji A, Siva A, Saip S, Constantinescu C, Akman-demir G, Arayssi T, et al. Treatment of neuro-Behçet's disease with infliximab: an international muticentre case-series of 18 patients [abstract]. Clin Exp Rheumatol 2010;28(Suppl 60):S119.
-
(2010)
Clin Exp Rheumatol
, vol.28
, Issue.SUPPL. 60
-
-
Al-Araji, A.1
Siva, A.2
Saip, S.3
Constantinescu, C.4
Akman-demir, G.5
Arayssi, T.6
|